ETFs & Funds
: Epizyme in the spotlight. Epigenetic mechanisms and DOT1L inhibition are one of the scientific spotlight sessions at ASH meeting
Add a reply...
Latest StockTalks »
people get EPZM breaking news and analysis by email alert.
Get email alerts on EPZM »
Get latest price
From other sites
Epizyme Teams Up with Roche's Genentech for Tazemetostat
at Zacks.com (Thu, 8:32AM)
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
at Zacks.com (Jun 20, 2016)
Earnings Estimates Moving Higher for Epizyme (EPZM): Time to Buy?
at Zacks.com (Jun 9, 2016)
Epizyme (EPZM) Reports Narrower-than-Expected Q1 Loss
at Zacks.com (May 10, 2016)
Epizyme (EPZM) Posts Narrower-Than-Expected Loss in Q1
at Zacks.com (May 9, 2016)